Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gee

Showing results (191-200 of 193) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 193 results.
Cancer Prevention Research (Philadelphia, Pa.)|February 2, 2012
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patientsEdward Messing, Jason R Gee, Daniel R Saltzstein, et al.
Nature Methods|March 27, 2018
Photoactivatable drugs for nicotinic optopharmacologySambashiva Banala, Matthew C Arvin, Nicholas M Bannon, et al.
JAMA|June 20, 2023
Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic StrokeBrian Mac Grory, DaJuanicia N Holmes, Roland A Matsouaka, et al.
Pageof 20

Showing results (191-200 of 193) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 193 results.
Cancer Prevention Research (Philadelphia, Pa.)|February 2, 2012
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patientsEdward Messing, Jason R Gee, Daniel R Saltzstein, et al.
Nature Methods|March 27, 2018
Photoactivatable drugs for nicotinic optopharmacologySambashiva Banala, Matthew C Arvin, Nicholas M Bannon, et al.
JAMA|June 20, 2023
Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic StrokeBrian Mac Grory, DaJuanicia N Holmes, Roland A Matsouaka, et al.
Pageof 20